GI

Cards (21)

  • Types of laxatives used for constipation

    • Osmotic (saline)
    • Stimulant (contact or irritants)
    • Bulk-forming
    • Emollient (stool softeners)
  • SHOULD ALWAYS BE AVOIDED IF PATIENT HAS AN INTESTINAL OBSTRUCTION
  • Osmotic (Saline) Laxatives
    Pull water into the colon and increase water in feces to increase bulk, which stimulates peristalsis and defecation. Produces semi-formed to watery stool
  • Osmotic (Saline) Laxatives

    • Lactulose
    • Glycerin
  • Stimulant (contact or irritants) Laxatives
    Increase peristalsis by irritating sensory nerve endings in the intestinal mucosa
  • Stimulant (contact or irritants) Laxatives
    • Bisacodyl (Dulcolax)
    • Castor Oil
    • Anthraquinones (Senna)
  • Stimulant (contact or irritants) Laxatives
    • Bisacodyl (Dulcolax) is the most frequently used and abused laxative (available OTC), PO works in 6-8 hours, Suppositories work in 15-60 min
    • Patient teaching point: change in urine color
  • Bulk-forming Laxatives

    Natural fibrous substances that promote large, soft stools by absorbing water into the intestine, fecal bulk and peristalsis, promotes well formed, soft stools
  • Bulk-forming Laxatives

    • Polycarbophil
    • Polyethylene glycol (MiraLAX)
    • Methylcellulose
    • Psyllium (Metamucil)
  • Emollient stool softeners

    Emollients are lubricants and stool softeners. Promote water accumulation in the intestine and stool. Helps to decrease straining during defecation
  • Emollient stool softeners

    • Docusate
  • Laxative Contraindications

    • Undiagnosed abdominal pain
    • Inflammatory disorders of the GI tract
    • Appendicitis
    • Diverticulitis
    • Ulcerative colitis
    • Spastic colon
    • Bowel obstruction
    • Pregnancy
  • Nursing Considerations for Laxatives

    • Assess history of constipation and possible causes, frequency and consistency of stools
    • Monitor fluid intake and output
    • Note evidence of fluid and electrolyte imbalance resulting from watery stools
    • Encourage patients to increase water intake
    • Advise patients to avoid overuse of laxatives
    • Warn patients that the drug is not for long-term use
    • Inform patients to consume foods high in fiber
  • Serotonin Receptor (5- HT3) Antagonist

    Blocks the serotonin (5-HT3) receptors in the CTZ and blocking the afferent vagal nerve terminals in the upper GI tract
  • Serotonin Receptor (5- HT3) Antagonist

    • Ondansetron (Zofran)
  • Serotonin Receptor (5- HT3) Antagonist

    • Most commonly used antiemetic
    • Side effects: CNS - HA, dizziness, fatigue; CV - hypotension, palpitations, edema
    • Does not block dopamine receptors therefore no EPS
    • Medicate 30 to 60 minutes prior to chemotherapy (PO, IV)
    • More effective when used with glucocorticoids
    • Most effective agents in N/V related to chemo/radiation/anesthesia
  • Diagnosis of Peptic Ulcer Disease (PUD)

    • Endoscopy -> biopsy sample
    • Breath test -> urea breath test
    • Serologic test -> igG antibodies specific
  • Treatment of Peptic Ulcer Disease (PUD)

    Triple therapy: Metronidazole (flagyl), Omeprazole (prilosec), Clarithromycin (cleocin)
  • Histamine -2 (H2) blockers

    Helps decrease/reduce gastric acid secretion, Prevents acid reflux in esophagus, Blocks h2 receptors
  • H2 blockers are less effective than Proton Pump Inhibitors (PPIs)
  • Proton Pump Inhibitors (PPIs)

    A drug class that suppresses gastric acid secretion by inhibiting the hydrogen/potassium ATPase enzyme located in the gastric parietal cells